Interactive molecular dynamics in virtual reality for accurate flexible protein-ligand docking
暂无分享,去创建一个
David R. Glowacki | Adrian J. Mulholland | Helen M. Deeks | Michael B. O'Connor | Michael B. O'Connor | Rebecca K. Walters | Stephanie R. Hare | A. Mulholland | D. Glowacki | Stephanie R Hare
[1] Supot Hannongbua,et al. Accurate prediction of protonation state as a prerequisite for reliable MM‐PB(GB)SA binding free energy calculations of HIV‐1 protease inhibitors , 2008, J. Comput. Chem..
[2] Tingjun Hou,et al. Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: mechanism for binding and drug resistance. , 2007, Journal of medicinal chemistry.
[3] W. Rutter,et al. Structural origins of substrate discrimination in trypsin and chymotrypsin. , 1995, Biochemistry.
[4] Frederick P. Brooks,et al. Project GROPEHaptic displays for scientific visualization , 1990, SIGGRAPH.
[5] C. Simmerling,et al. ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. , 2015, Journal of chemical theory and computation.
[6] Rosalind J Allen,et al. Forward flux sampling for rare event simulations , 2009, Journal of physics. Condensed matter : an Institute of Physics journal.
[7] Todd J Martínez,et al. Ab initio interactive molecular dynamics on graphical processing units (GPUs). , 2015, Journal of chemical theory and computation.
[8] Oussama Metatla,et al. Sampling molecular conformations and dynamics in a multiuser virtual reality framework , 2018, Science Advances.
[9] Ron O. Dror,et al. Molecular Dynamics Simulation for All , 2018, Neuron.
[10] A. Caflisch,et al. Molecular dynamics in drug design. , 2015, European journal of medicinal chemistry.
[11] A. Cavalli,et al. Dynamic Docking: A Paradigm Shift in Computational Drug Discovery , 2017, Molecules.
[12] M. Karplus,et al. Molecular dynamics and protein function. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[13] Sébastien Limet,et al. Interactive Molecular Dynamics: Scaling up to Large Systems , 2013, ICCS.
[14] Robert V. Swift,et al. Mechanism of 150-cavity formation in influenza neuraminidase , 2011, Nature communications.
[15] Klaus Schulten,et al. A system for interactive molecular dynamics simulation , 2001, I3D '01.
[16] S. Naem. The role of neuraminidase inhibitors in the treatment and prevention of influenza , 2001, Journal of Biomedicine and Biotechnology.
[17] Gerhard Wolber,et al. The impact of molecular dynamics on drug design: applications for the characterization of ligand-macromolecule complexes. , 2015, Drug discovery today.
[18] W. E,et al. Finite temperature string method for the study of rare events. , 2002, Journal of Physical Chemistry B.
[19] Klaus Schulten,et al. Adaptive Multilevel Splitting Method for Molecular Dynamics Calculation of Benzamidine-Trypsin Dissociation Time. , 2016, Journal of chemical theory and computation.
[20] David Chandler,et al. Transition path sampling: throwing ropes over rough mountain passes, in the dark. , 2002, Annual review of physical chemistry.
[21] Parimal Kar,et al. Energetic basis for drug resistance of HIV-1 protease mutants against amprenavir , 2012, Journal of Computer-Aided Molecular Design.
[22] S. Bhakat,et al. Flap Dynamics in Aspartic Proteases: A Computational Perspective , 2016, Chemical biology & drug design.
[23] Rommie E. Amaro,et al. Ensemble Docking in Drug Discovery. , 2018, Biophysical journal.
[24] George F. Gao,et al. Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor binding , 2013, Scientific Reports.
[25] Qinggang Zhang,et al. Revealing Origin of Decrease in Potency of Darunavir and Amprenavir against HIV-2 relative to HIV-1 Protease by Molecular Dynamics Simulations , 2014, Scientific Reports.
[26] G. Klebe,et al. Intriguing role of water in protein-ligand binding studied by neutron crystallography on trypsin complexes , 2018, Nature Communications.
[27] Mark C. Surles,et al. Sculpting proteins interactively: Continual energy minimization embedded in a graphical modeling system , 1994, Protein science : a publication of the Protein Society.
[28] W G Laver,et al. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. , 1997, Journal of the American Chemical Society.
[29] Yoshihiro Kawaoka,et al. Influenza: lessons from past pandemics, warnings from current incidents , 2005, Nature Reviews Microbiology.
[30] Daniel Pargman,et al. Computing within limits , 2018, Commun. ACM.
[31] Chi‐Huey Wong,et al. HIV-1 protease: mechanism and drug discovery. , 2003, Organic & biomolecular chemistry.
[32] Manthos G. Papadopoulos,et al. Computational Studies of Darunavir into HIV-1 Protease and DMPC Bilayer: Necessary Conditions for Effective Binding and the Role of the Flaps , 2012, J. Chem. Inf. Model..
[33] Mark E Tuckerman,et al. Molecular dynamics study of the connection between flap closing and binding of fullerene-based inhibitors of the HIV-1 protease. , 2003, Biochemistry.
[34] S. Doerr,et al. On-the-Fly Learning and Sampling of Ligand Binding by High-Throughput Molecular Simulations. , 2014, Journal of chemical theory and computation.
[35] F. Noé,et al. Protein conformational plasticity and complex ligand-binding kinetics explored by atomistic simulations and Markov models , 2015, Nature Communications.
[36] Y. Yonetani. Water access and ligand dissociation at the binding site of proteins. , 2018, The Journal of chemical physics.
[37] K. Schulten,et al. Mechanisms of selectivity in channels and enzymes studied with interactive molecular dynamics. , 2003, Biophysical journal.
[38] D. M. Ryan,et al. Rational design of potent sialidase-based inhibitors of influenza virus replication , 1993, Nature.
[39] Frederick P. Brooks,et al. Force display performs better than visual display in a simple 6-D docking task , 1989, Proceedings, 1989 International Conference on Robotics and Automation.
[40] Adrian J Mulholland,et al. An open-source multi-person virtual reality framework for interactive molecular dynamics: from quantum chemistry to drug binding , 2019, The Journal of chemical physics.
[41] R. Stroud,et al. Structure and specific binding of trypsin: comparison of inhibited derivatives and a model for substrate binding. , 1974, Journal of molecular biology.
[42] J. Tuszynski,et al. Software for molecular docking: a review , 2017, Biophysical Reviews.
[43] Kent R. Wilson,et al. Computing with feeling , 1977, Comput. Graph..
[44] M. Levitt. A simplified representation of protein conformations for rapid simulation of protein folding. , 1976, Journal of molecular biology.
[45] A. Roitberg,et al. pH-REMD simulations indicate that the catalytic aspartates of HIV-1 protease exist primarily in a monoprotonated state. , 2014, The journal of physical chemistry. B.
[46] Amedeo Caflisch,et al. Protein structure-based drug design: from docking to molecular dynamics. , 2018, Current opinion in structural biology.
[47] K. Hertogs,et al. Binding Kinetics of Darunavir to Human Immunodeficiency Virus Type 1 Protease Explain the Potent Antiviral Activity and High Genetic Barrier , 2007, Journal of Virology.
[48] David R. Glowacki,et al. Training neural nets to learn reactive potential energy surfaces using interactive quantum chemistry in virtual reality , 2019, The journal of physical chemistry. A.
[49] William E. Hart,et al. Robust Proofs of NP-Hardness for Protein Folding: General Lattices and Energy Potentials , 1997, J. Comput. Biol..
[50] E. Baker,et al. Hydrogen bonding in globular proteins. , 1984, Progress in biophysics and molecular biology.
[51] Simon McIntosh-Smith,et al. Adaptive free energy sampling in multidimensional collective variable space using boxed molecular dynamics. , 2016, Faraday discussions.
[52] J. Richardson,et al. Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation. , 1999, Journal of molecular biology.
[53] M. Murcko,et al. Crystal Structure of HIV-1 Protease in Complex with Vx-478, a Potent and Orally Bioavailable Inhibitor of the Enzyme , 1995 .
[54] Fabio Polticelli,et al. Structural determinants of trypsin affinity and specificity for cationic inhibitors , 1999, Protein science : a publication of the Protein Society.
[55] Ashima Bagaria,et al. Molecular Dynamics Simulation of Proteins: A Brief Overview , 2014 .
[56] Stéphane Redon,et al. Interactive chemical reactivity exploration. , 2014, Chemphyschem : a European journal of chemical physics and physical chemistry.
[57] Rommie E. Amaro,et al. SEEKR: Simulation Enabled Estimation of Kinetic Rates, A Computational Tool to Estimate Molecular Kinetics and Its Application to Trypsin-Benzamidine Binding. , 2017, The journal of physical chemistry. B.
[58] M. Karplus,et al. Dynamics of folded proteins , 1977, Nature.
[59] Gregory R Bowman,et al. FAST Conformational Searches by Balancing Exploration/Exploitation Trade-Offs. , 2015, Journal of chemical theory and computation.
[60] Victor Guallar,et al. Computational Prediction of HIV-1 Resistance to Protease Inhibitors , 2016, J. Chem. Inf. Model..
[61] Markku Hämäläinen,et al. Elucidation of HIV-1 protease resistance by characterization of interaction kinetics between inhibitors and enzyme variants. , 2003, Antiviral research.
[62] G. de Fabritiis,et al. Complete reconstruction of an enzyme-inhibitor binding process by molecular dynamics simulations , 2011, Proceedings of the National Academy of Sciences.
[63] Mark von Itzstein,et al. The war against influenza: discovery and development of sialidase inhibitors. , 2007, Nature reviews. Drug discovery.
[64] Christopher J. Woods,et al. Computational Assay of H7N9 Influenza Neuraminidase Reveals R292K Mutation Reduces Drug Binding Affinity , 2013, Scientific Reports.